Trial intelligence / Profile preview

Acetaminophen for AKI in Aortic Surgery

NCT04882202Recruiting

Sponsor
Gangnam Severance Hospital
Start
Oct 2021
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in acute kidney injury (AKI) comparing Acetaminophen group with Placebo group (2 arms). Primary endpoint: Incidence of acute kidney injury at 7 days. Started Oct 2021; status: recruiting.

02

Drugs

acetaminophen
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT04882202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04882202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call